Ask the Pharmacy – Are you getting the lowest cost for your PCSK9 inhibitor?
The manufacturers of both PCSK9 inhibitors, Praluent and Repatha, have lowered the list price for these cholesterol-lowering treatments by 60% to $5,850 per year. As we reported in February, the FH Foundation continues … Read More
Editor’s note: Today, Mike Smith shares how high cholesterol and heart disease took a toll on his family for generations. Until the day he had a proper diagnosis of familial hypercholesterolemia, and he knew he could manage it.
My story goes back longer than I can remember. I have a great … Read More
Statins are one of the longest and most well-studied drugs that definitively provide positive results. In fact, the most-effective statins reduce cholesterol by 55-50% at their maximum dose. In addition, statins are cost-effective — 6 of the 7 statins are generic. While statins save lives world-wide, … Read More
Today, 23andMe announced a new Genetic Health Risk Report for Familial Hypercholesterolemia.
Now, individuals who are 23andMe Health+ Ancestry service customers will be alerted if they have one of 24 of the more common gene variants for Familial Hypercholesterolemia (FH) that can be analyzed. Since … Read More
Familial Hypercholesterolemia can have devastating consequences – stealing people away from the people who love them. Today, we are honored to share this story from community member April Irene Donelson. April lost her fiancée to a sudden heart attack just months before they were to be married. … Read More
The FH Foundation welcomes Sanofi and Regeneron’s announcement today to lower the list price of its LDL cholesterol lowering treatment, the PCSK9 inhibitor Praluent, to $5,850 annually. This brings the list price of Praluent in line with Amgen’s PCSK9 inhibitor, Repatha, which was lowered … Read More
The FH Foundation went to Capitol Hill on January 28-29 to raise awareness of Familial Hypercholesterolemia among our nation’s elected officials, and advocate for Federal funding for FH research.
Our 2019 class of 25 new volunteer FH Advocates for Awareness held 36 meetings with Congressional Offices … Read More
(BPT) One in four deaths in the U.S. is caused by heart disease. More than 610,000 people die of heart disease in the U.S. every year, making it the leading cause of death for both men and women, according to the Centers for Disease Control and Prevention. It’s no surprise heart health … Read More
FH Foundation Driving Global Policy Collaborations with the World Heart Federation and International FH Community
In December 2018, three FH Foundation team members — Katherine Wilemon, founder and CEO, Dr. Sam Gidding, chief medical officer, and Jasmine Patel, community relations manager — … Read More
The December issue of O Magazine (Oprah Magazine) highlights familial hypercholesterolemia (FH) and genetic testing! However, not all genetic testing is the same.
The feature 10 Factors You Should Consider Before Taking an at-Home DNA Test includes two quotes from Dr. Dan Rader, the FH Foundation’s … Read More